DALLAS, Jan. 31, 2013 /PRNewswire/ -- X-Change Corporation (NASDAQOTC :XCHC ), a U.S. publicly-traded company, through its European joint venture with Dupetit Natural Products, GmbH, announces that within one week the Company will move into the testing stage of development of its unique hemp-based Phytiva brand of products, as the Company prepares to bring these products to European and North American markets.
The first testers of these Phytiva Brand products are ready for production and packaging and will include anti-aging skin care and rejuvenation products, including hemp-based lip balms, supplements, moisturizers, and sunscreen. After testing these products, the Company will aggressively market them for over-the-counter (OTC) sales targeting a wide range of cosmetic and ailment-related usages.
"The Company is moving even more quickly than anticipated in creating testers for its initial hemp-based Phytiva Brand products; therefore, we are excited to announce that these cutting-edge products will be brought to market sooner than expected," said Chad S. Johnson, Esq., Chief Operating Officer of X-Change Corporation.
About X-Change Corp.
X-Change Corp. has acquired both the Phytiva Brand of products and all associated rights and Companies and the European JV with Dupetit from Cannabis Science, Inc. The Phytiva products acquired by X-Change Corp. are unique hemp-inclusive products for skin care and rejuvenation. These are the first products of the company to be released publicly. These initial products include lip balms, extracts, supplements, and dermal creams, targeting a wide range of cosmetic and ailment-related usages.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
SOURCE X-Change Corp.